Clinical Trials
88 trialsOptimal Tube Feeding Method in Head and Neck Cancer Patients
Baylor Research Institute
GIRAFE
Institut Claudius Regaud
Quality of Life Assessment of Radiotherapy in Recurrent Head and Neck Cancer
University of Oklahoma
Implementation of a Standardized Tracheostomy Education Discharge Protocol
Case Comprehensive Cancer Center
Neoadjuvant Radiotherapy Plus Targeted Therapy and Immunotherapy vs. Targeted Therapy Plus Immunotherapy in Resectable HNSCC
West China Hospital
Online Peri-operative Education Program for Patients Undergoing Major Head & Neck Surgery
Washington University School of Medicine
Intraoperative Identification and Stimulation of the Glossopharyngeal Nerve
Vanderbilt University Medical Center
Torisel in Addition to Standard Chemotherapy With Radiation for Advanced Head and Neck Cancer
Thomas Jefferson University
Sparing Parotid Ducts Via MRI Sialography for Reduced Patient Reported Xerostomia
UNC Lineberger Comprehensive Cancer Center
SupCare
European Organisation for Research and Treatment of Cancer - EORTC
Study of Front Line Pembrolizumab and Valemetostat in PD-L1 Positive, HPV-Negative Recurrent/Metastatic Squamous Cell Carcinoma (SCC) of the Head and Neck: The PANTHERAS
National Institutes of Health Clinical Center (CC)
A Study of HB-202/HB-201 With Pembrolizumab in Patients With HPV16+ Recurrent/Metastatic Oropharyngeal Cancer
Hookipa Biotech GmbH
NICAP
Eurofarma Laboratorios S.A.
Mood Disorders in Head and Neck Cancer Patients
University of Alabama at Birmingham
Functional and Molecular Characterization of Treatment Response in Tumors in the Oral Cavity Using Optical Spectroscopy
University of Arkansas
I-PAP
University of Nebraska
stREnGTH
University Hospital, Ghent
Oral AHR Antagonist in Combination With Nivolumab in Patients With PD-1 Resistant Metastatic or Recurrent Head and Neck Cancer
Ikena Oncology
OU-SCC VR
University of Oklahoma
Efficacy of Ketamine Mouthwash in the Management of Oral and Pharyngeal Toxicity Associated With Head and Neck Chemoradiotherapy: A Phase 2, Simon 2-stage Trial
Northwell Health
Venlafaxine for the Prevention of Depression in Patients With Head and Neck Cancer
Vanderbilt University Medical Center
PANTHEoN
Vanderbilt-Ingram Cancer Center
Phase 2 Study of Neoadjuvant SAR444245 Plus Cemiplimab in HPV Related Oropharynx Squamous Cell Carcinoma
M.D. Anderson Cancer Center
Prospective Analysis of Effect of Collagen Wrap Conduit on Radial and Ulnar Nerve Function Following Radial/Ulnar Forearm Free Flap Harvest
The University of Texas Health Science Center, Houston
Role of Pharyngeal High Resolution Manometry and Impedance in Swallow Function of Head and Neck Cancer Patients
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
RM-1995 Photoimmunotherapy, as Monotherapy or Combined With Pembrolizumab, in Patients With Advanced CuSCC and HNSCC
Rakuten Medical, Inc.
EndoRest
Abramson Cancer Center at Penn Medicine
Effect of N-Acetyl Cysteine (NAC) on the Oral Microbiome
Wake Forest University Health Sciences
Ideal Drainage Output of Post-operative Neck Suction Drain
Centre hospitalier de l'Université de Montréal (CHUM)
CIVO Intratumoural Microdosing of Anti-Cancer Therapies in Australia
Presage Biosciences
Feasibility and Safety of Aerobic Exercise for Head and Neck Cancer Patients
Vanderbilt University
Enoblituzumab Plus MGA012 or MGD013 in Squamous Cell Carcinoma of the Head and Neck
MacroGenics
Pseudo-Simultaneous Imaging of Tumor Hypoxia and Proliferation in HNC Patients Using PET/CT
Weill Medical College of Cornell University
SPEARHEAD 2 Study in Subjects With Recurrent or Metastatic Head and Neck Cancer
Adaptimmune
CASP-ORL
Jessa Hospital
Trial of BMX-001 or Placebo in Head and Neck Cancer Patients
BioMimetix JV, LLC
ESMULLLAT
Institut Claudius Regaud
CECAVI
Odense University Hospital
AMD3100 Plus Pembrolizumab in Immune Checkpoint Blockade Refractory Head and Neck Squamous Cell Carcinoma
Massachusetts General Hospital
Lymphedema Treatment in Head and Neck Cancer Patients
Endeavor Health
Pre-Operative Pregabalin for Post-Operative Pain in Head and Neck Cancer Surgery
Augusta University
IRAM
Institut de Cancérologie de la Loire
Intraoperative Imaging of a PET Positive Lymph Node(s) Using 18FDG and a Dual-Mode, Hand-Held Intraoperative Imager
University of Arkansas
Study Comparing AlloVaxâ„¢ to Chemotherapy in Recurrent/Metastatic Squamous Cell Carcinoma of the Head & Neck
Mirror Biologics, Inc.
Nivolumab Plus Epacadostat in Combination With Chemotherapy Versus the EXTREME Regimen in Squamous Cell Carcinoma of the Head and Neck (CheckMate 9NA/ECHO-310)
Incyte Corporation
Phenylbutyrate and Valganciclovir in Treating Patients With Relapsed or Refractory Epstein-Barr Virus-Positive Cancer
University of California, San Diego
Regional Anesthesia Block in Fibula Free Flap Reconstruction
University of Florida
Neoadjuvant Pembrolizumab + Epacadostat Prior to Curative Surgical Care for Squamous Cell Carcinoma of the Head and Neck
University of Chicago
An Immuno-therapy Study of Nivolumab in Combination With Experimental Medication BMS-986205 Compared to Standard of Care EXTREME Regimen in First-line Recurrent/Metastatic Squamous Cell Carcinoma of Head and Neck
Bristol-Myers Squibb
Image Guided Intensity Modulated Reirradiation (IG-IMRT) With Cetuximab for Locoregionally Confined Recurrent Head and Neck Squamous Cell Carcinoma
Milton S. Hershey Medical Center